NSC |
Compound |
Enrichment |
Correlation |
NSC 694509 |
Null |
0.0392716453377535 |
-0.079470068 |
NSC 699934 |
Null |
0.0392716453377535 |
-0.31335385 |
NSC 709358 |
1H-Pyrrole-2-carboxamide, N-[3-(dimethylamino)propyl]-1-methyl-4-[[[1-methyl- 4-[[1-oxo-4-[[(2,3,5,11a-tetrahydro-7-methoxy-5-oxo- 1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl]oxy]butyl]amino]- 1H-pyrrol |
0.0392716453377535 |
0.15285538 |
NSC 711077 |
Null |
0.0392716453377535 |
0.35071433 |
NSC 715407 |
Null |
0.0392716453377535 |
0.36639803 |
NSC 720495 |
Null |
0.0392716453377535 |
0.38701031 |
NSC 726442 |
4,11-dihydroxy-3-{[4-(2-hydroxyethyl)-1-piperazinyl]methyl}- 1H-naphtho[2,3-f]indole-5,10-dione dihydrochloride |
0.0392716453377535 |
0.17295058 |
NSC 730009 |
cis-2,5,6,12,13-Pentahydro-6-methyl-(8,9-methylenedioxy)-3-n itro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline |
0.0392716453377535 |
0.10798977 |
NSC 732205 |
Null |
0.0392716453377535 |
-0.0094233049 |
NSC 732962 |
5-amino-4-(1,3-benzothiazol-2-yl)-1-(2-chloro-5-trifluoromet hylphenyl)-2,3-dihydro-1H-3-pyrrolone |
0.0392716453377535 |
0.32288801 |